Winners of BioSpectrum Asia Pacific BioScience Industry Award 2011

Specials |  News | By BioSpectrum Bureau  | 0 Comment | 30 Apr, 2012

Life Time Achievement Award: Dr Yusuf K Hamied, IndiaPerson of the Year Award: Dr Silviu Itescu, AustraliaEntrepreneur of the Year Award: Dr Weidong Yin, China Product of the Year AwardSpy...Read more

Winners of BioSpectrum Asia Pacific BioScience Industry Award 2010

Specials |  News | By BioSpectrum Bureau  | 0 Comment | 30 Apr, 2012

Life Time Achievement Award: Dr Kallam Anji Reddy, IndiaPerson of the Year: Dr Brian McNamee, AustraliaEntrepreneur of the Year: Dr Xiaochuan Wang, China Product of the YearOvPlex, HealthL...Read more

Affordable cancer diagnostics wins VolitionRx BioSpectrum award

Specials |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

Driven by the demand for affordable and simple diagnostics, VolitionRx has been focusing on diagnostic tests for cancer that are as simple and easy-to-use as the diabetes and cholesterol te...Read more

We will invest for innovating TB control strategies'

Specials |  News | By BioSpectrum Bureau  | 0 Comment | 22 Mar, 2012

Bill & Melinda Gates Foundation is the largest transparently operated private foundation in the world, founded by Bill and Melinda Gates with the aim of enhancing healthcare and reducin...Read more

Ranbaxy retains grip on generics market

Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2013

Ranbaxy became the first Indian firm to develop a new drug called Synriam for malaria, which is a health menace that claims half a million lives worldwide each year. In 2012, Ranbaxy mana...Read more

Lupin gets 16 FDA nods, launches 11 products front

Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

US remained an unstirred focus for Indian pharmaceutical company Lupin as it went on achieving 16 approvals from US FDA and launched 11 products during 2012. Besides building a strong gri...Read more

CSL marks a billion dollar in profits

Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 31 May, 2013

One of Asia Pacific's biggest names in the pharmaceutical industry, CSL, retained its second position in BioSpectrum Asia's Top 20 list. The pharmaceutical giant recorded net profit of $1...Read more

Aricept leads Japan pharma market with $1.81 bn

Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2012

The top 10 pharmaceutical products being sold in the Japanese market, by both local and foreign players, contribute to about 10 percent of the $120 billion pharmaceutical market, says an IM...Read more

Achira weaves microfluidics into diagnostics

Specials |  Influencers | By BioSpectrum Bureau  | 0 Comment | 23 May, 2012

In what can be termed as the perfect blend of an old art and new technology, a small start-up in Bangalore, India, is trying to apply a cutting edge science like microfluidics to the centur...Read more

Challenge No 5: Talent trouble

Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 17 May, 2012

Lack of trained and skilled workforce, identifying a market-savvy work force and retaining the right people on key positions are problems in certain regions, especially for conducting R&...Read more

Green fuel pioneer Sean Simpson wins BioSpectrum award

Specials |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

With the need for green fuel technologies growing bigger every day, New Zealand company LanzaTech is providing an alternative solution to the energy crisis. Stepping away from the conventio...Read more

Shanghai BravoBio wins BioSpectrum award for role in China vaccine industry

Specials |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

Chinese vaccine development companies are raising the bar to meet international standards. However, access to foreign markets remains a challenge. Shanghai BravoBio, which has a strong and ...Read more

Cipla keeps the flag high for affordable drugs

Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

Cipla, which is known for providing affordable drugs to cancer and HIV patients in developing countries, clocked a growth of 17 percent in the year ending 2012. The domestic turnover incr...Read more

Samantha Su, Simranjit Singh: Finding skilled professionals is a challenge in Singapore

Specials |  Opinion | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

In the biomedical sector, the combination of latest technology and a strong business model is considered to be ideal. Theoretically, the synergy created between them spurs the company to bu...Read more

Dong-A Pharma diversifies portfolio to include biosimilars

Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

Clocking revenues of $995.40 million, Dong-A pharmaceutical is acknowledged as a leading name in Korea's pharmaceutical industry. Over the years, the company has built alliances with inte...Read more

International Clinical trials day Special: Asia's clinical trials landscape

Specials |  News | By BioSpectrum Bureau  | 0 Comment | 20 May, 2015

Singapore: Clinical trials were once undertaken largely in the West. However many Asian countries are now emerging as top destinations for clinical trials. For more than a decade, the emerg...Read more

Mindray Medical is set to penetrate the medtech market

Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

Mindray Medical created a strong name in a wide array of medical devices and consumables. It is further complementing its product line with acquisitions that took place in 2012. The compa...Read more

Sino Biopharma banks on quality manufacturing

Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

Sino Biopharmaceutical, an integrated name in R&D, manufacturing and marketing of health enhancing modernized Chinese medicines and chemical medicines, has continued to be a quality o...Read more